OIC Intramedullary Nail System

K181184 · The Orthopaedic Implant Company · HSB · Jul 27, 2018 · Orthopedic

Device Facts

• Record ID: K181184
• Device Name: OIC Intramedullary Nail System
• Applicant: The Orthopaedic Implant Company
• Product Code: HSB · Orthopedic
• Decision Date: Jul 27, 2018
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3020
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The OIC Intramedullary Nail System is intended for surgical management of femoral and tibial fractures including open and closed fractures, pseudarthrosis and correction osteotomy, pathologic fractures, impending pathologic fractures, tumor resections, nonunions and malunions. The hip nay be used for basilar neck, subtrochanteric and intertrochanteric fractures. The femoral nails may be used for fractures of the femur below the hip joint including ipsilateral femur fractures, fractures proximal to a total knee arthroplasty and supracondylar fractures, including those with intra-articular extension.

Device Story

OIC Intramedullary Nail System comprises titanium alloy (Ti-6Al-4V ELI) intramedullary nails, locking bolts, and lag screws; used for internal fixation of long bone fractures. System includes surgical instruments for implantation, including tools for suprapatellar tibial nail insertion. Used by orthopedic surgeons in clinical/OR settings. Device provides mechanical stabilization of bone fractures to facilitate healing. Substantial equivalence established via geometric comparison of added instruments to predicate systems. No clinical data required; mechanical characteristics verified via bench testing.

Clinical Evidence

Bench testing only. No clinical data provided. Substantial equivalence supported by geometric comparison of added instruments to predicate devices.

Technological Characteristics

Nails, bolts, and screws: Ti-6Al-4V ELI titanium alloy. Instruments: surgical grade stainless steel or 6061-T6 aluminum with medical grade silicone or Radel handles. System is non-sterile. Mechanical fixation via intramedullary rod and locking hardware.

Indications for Use

Indicated for patients requiring surgical management of femoral and tibial fractures, including open/closed fractures, pseudarthrosis, correction osteotomy, pathologic/impending pathologic fractures, tumor resections, nonunions, and malunions. Hip nails indicated for basilar neck, subtrochanteric, and intertrochanteric fractures. Femoral nails indicated for fractures below the hip joint, ipsilateral femur fractures, fractures proximal to total knee arthroplasty, and supracondylar fractures with intra-articular extension.

Regulatory Classification

Identification

An intramedullary fixation rod is a device intended to be implanted that consists of a rod made of alloys such as cobalt-chromium-molybdenum and stainless steel. It is inserted into the medullary (bone marrow) canal of long bones for the fixation of fractures.

Predicate Devices

• OIC Intramedullary Nail System (K150655)
• ZNN System Tibial Nail and Stainless Steel Tibial Nail (K130595)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

The Orthopaedic Implant Company Douglas Fulton Quality and Operations Manager 770 Smithridge Dr. Suite 400 Reno, Nevada 89502

July 27, 2018

Re: K181184

Trade/Device Name: OIC Intramedullary Nail System Regulation Number: 21 CFR 888.3020 Regulation Name: Intramedullary Fixation Rod Regulatory Class: Class II Product Code: HSB Dated: June 27, 2018 Received: June 28, 2018

Dear Douglas Fulton:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely.

# Mark N. Melkerson -S

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Form Approved: OMB No. 0910-0120

Expiration Date: 06/30/2020

See PRA Statement below.

#### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

# Indications for Use

510(k) Number (if known)

K181184

Device Name

OIC Intramedullary Nail System

#### Indications for Use (Describe)

The OIC Intramedullary Nail System is intended for surgical management of femoral and tibial fractures including open and closed fractures, pseudarthrosis and correction osteotomy, pathologic fractures, impending pathologic fractures, tumor resections, nonunions and malunions. The hip nay be used for basilar neck, subtrochanteric and intertrochanteric fractures. The femoral nails may be used for fractures of the femur below the hip joint including ipsilateral femur fractures, fractures proximal to a total knee arthroplasty and supracondylar fractures, including those with intra-articular extension.

Type of Use (Select one or both, as applicable)

> Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

### 510(k) Summary

Prepared 05/01/2018

### Name and Address of Manufacturer

The Orthopaedic Implant Company (OIC) 770 Smithridge Dr. Suite 400 Reno, NV 89502

### Contact

Douglas Fulton Quality Assurance Manager Telephone: [phone] Fax: [phone] Email: [e-mail]

### Device Identification

Trade Name: OIC Intramedullary Nail System Common Name: Hip Nail, Femoral Nail, Tibial Nail Classification Name: Rod, Fixation, Intramedullary and Accessories Classification: Class II, 21 CFR 888.3020 Panel: Orthopedic Product Code: HSB

### Purpose of filing

This filing is being submitted to add fifteen instruments to the OIC Intramedullary Nail System. Seven of these instruments are miscellaneous instruments to aid in installing or extracting the instruments are tools that will enable the tibial nails to be inserted using the suprapatellar approach with the knee joint in a semi-extended position.

### Indications for Use

The OIC Intramedullary Nail System is intended for surgical management of femoral and tibial fractures including open and closed fractures, pseudarthrosis and correction osteotomy, pathologic fractures, tumor resections, nonunions and malunions. The hip nails may be used for basilar neck, subtrochanteric and intertrochanteric fractures. The femoral nails may be used for fractures of the hip joint including ipsilateral femur fractures fractures proximal to a total knee arthroplasty and supracondvlar fractures, including those with intraarticular extension.

#### Device Description

The OIC Intramedullary Nail System consists of the tibia and femur, nail locking bolts, lag screws and instruments for implantation. The nails come in a variety of sizes and are pre-contoured to match the anatomy of the patient and accept 5.0mm locking bolts range in length from 20mm to 130mm. The lad screws are 10.5mm in diameter and range in length from 70mm to 120mm.

The intramedullary nails, bolts and screws are made of titanium alloy Ti-6Al-4V ELI.

The additional instruments being added to the OIC Intramedullary Nail System are provided in the non-sterile condition. They are made of surgical grade stainless steel or 6061-T6 Aluminum with a medical grade silicone or Radel handle.

## Substantial Equivalence

Primary predicate device: OIC Intramedullary Nail System K150655 Additional predicate devices:

System Modification - ZNN System Tibial Nail and Stainless Steel Tibial Nail K130595

The new device is substantially equivalent to the predicate devices in regard to intended use, materials, and function. There are no significant differences between the OIC Intramedullary Nail System and the predicate devices listed above. Any minor differences have no effect on safety and effectiveness.

The added instruments of the OIC Intramedullary Nail System were evaluated using a geometric comparison to the predicate devices. The instrument constructs were found to have acceptable mechanical characteristics for the intended uses.